EUVIMEDEUVIMED entdecken
Crossref

Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validation

Dan Wu, Qiu Lin, Zhuo Wang, Hua Huang, Xiudao Song, Yin Gao, Xiao Yang, Ke Wen, Xueliang Sun

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.156169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Dan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215000, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Crohn Disease, Atherosclerosis, Toll-Like Receptor 4. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Suzhou City Science and Technology Bureau, Jiangsu Commission of Health, Nanjing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Crohn's disease (CD), as a chronic systemic inflammatory disease, is strongly associated with the development of premature atherosclerosis (AS). Atherosclerotic cardiovascular disease, including coronary heart disease, myocardial infarction and stroke, is a lethal complication of CD. Nowadays, there is a lack of effective monotherapy for CD complicated by AS. PURPOSE: To explore the underlying effects and mechanisms of Xue-Jie-San (XJS) on treating CD complicated by AS via network pharmacology and experimental validation. METHODS: The targets of XJS components were obtained from TCMSP, ETCM and PubChem databases as well as the disease genes of CD and AS from GeneCards, DisGeNET and OMIM databases. The core targets were screened out from the drug-disease common targets identified by protein-protein interaction (PPI) network analysis and then analyzed with GO and KEGG enrichment. The interaction between core target and XJS component was detected by molecular docking and molecular dynamics simulation. Subsequently, the core targets were validated via GEO datasets and their biological functions were confirmed in vitro. Nile red staining was used to evaluated lipid accumulation in human umbilical vein endothelial cells (HUVECs) challenged by lipopolysaccharide (LPS) combined with oxidized low-density lipoprotein (ox-LDL). Levels of pro-inflammatory cytokines were examined by enzyme-linked immunosorbent assay. Chemokine CCL2 and CXCL8 were detected by immunofluorescence staining. The activity of the TLR4/Myd88/NF-κB signaling pathway was assessed using Western blot. RESULTS: In total, 26 common target genes of XJS, CD and AS were found. Among them, 11 core genes were identified by PPI network analysis. The effects of XJS treating CD complicated by AS were mainly mediated by the lipid and atherosclerosis pathway, inflammatory bowel disease pathway and toll-like receptor signaling pathway. Molecular docking and molecular dynamics simulation displayed strong binding affinity between XJS component and the core target. Six core genes including TLR4, IL-1β, TNF, ICAM1, CCL2 and CXCL8 were validated by GEO datasets. In vitro, the effects of XJS on reducing lipid accumulation, secretion of IL-1β, IL6, TNF-α, CCL2 and CXCL8, and the protein expressions of TLR4, Myd88, p-p65 and ICAM1 were verified. CONCLUSION: XJS is a potential candidate drug for the treatment of CD complicated by AS. The underlying mechanisms involve mitigation of lipid accumulation-mediated endothelial dysfunction and blockage of immune inflammatory response by targeting TLR4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationCrohn DiseaseAtherosclerosisToll-Like Receptor 4Network PharmacologyDrugs, Chinese HerbalHumansHuman Umbilical Vein Endothelial CellsMyeloid Differentiation Factor 88Protein Interaction MapsSignal TransductionChemokine CCL2Lipoproteins, LDLIntercellular Adhesion Molecule-1Interleukin-8Molecular Dynamics SimulationNF-kappa B

Stichwörter der Autor:innen

AtherosclerosisCrohn's diseaseNetwork pharmacologyTLR4Xue-Jie-San

Substanzen

Toll-Like Receptor 4Drugs, Chinese HerbalTLR4 protein, humanMyeloid Differentiation Factor 88Chemokine CCL2oxidized low density lipoproteinLipoproteins, LDLIntercellular Adhesion Molecule-1MYD88 protein, humanCCL2 protein, human

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215000, China.
  • Department of Colorectal Surgery, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210000, China.
  • Department of Clinical Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215000, China.
  • Department of Anorectal Surgery, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu 215500, China.
  • Clinical Pharmaceutical Laboratory of Traditional Chinese Medicine, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215000, China.
  • Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215000, China. Electronic address: sunxueliang-2005@163.com.

Förderung

  • Suzhou City Science and Technology Bureau
  • Jiangsu Commission of Health
  • Nanjing University of Chinese Medicine

Zitieren

APA

Wu, D., Lin, Q., Wang, Z., Huang, H., Song, X., Gao, Y., Yang, X., Wen, K., & Sun, X. (2024). Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validation. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156169

Vancouver

Wu D, Lin Q, Wang Z, Huang H, Song X, Gao Y, et al. Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validation. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.156169

BibTeX
@article{Wu2024,
  author = {Wu, Dan and Lin, Qiu and Wang, Zhuo and Huang, Hua and Song, Xiudao and Gao, Yin and Yang, Xiao and Wen, Ke and Sun, Xueliang},
  title = {Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validation},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.156169}
}
Kostenlos starten →